ATE445704T1 - Expressionsvektor für tierische zellen - Google Patents

Expressionsvektor für tierische zellen

Info

Publication number
ATE445704T1
ATE445704T1 AT01957013T AT01957013T ATE445704T1 AT E445704 T1 ATE445704 T1 AT E445704T1 AT 01957013 T AT01957013 T AT 01957013T AT 01957013 T AT01957013 T AT 01957013T AT E445704 T1 ATE445704 T1 AT E445704T1
Authority
AT
Austria
Prior art keywords
vector
expression vector
present
animal cells
expression
Prior art date
Application number
AT01957013T
Other languages
English (en)
Inventor
Jong-Mook Kim
Jung-Seob Kim
Sun-Mo Oh
Jae-Seung Yoon
Kwang-Hee Baek
Soo-Il Chung
Doo-Hong Park
Yeup Yoon
Original Assignee
Mogam Biotech Res Inst
Neurotech Pharmaceuticals Co L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogam Biotech Res Inst, Neurotech Pharmaceuticals Co L filed Critical Mogam Biotech Res Inst
Application granted granted Critical
Publication of ATE445704T1 publication Critical patent/ATE445704T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01957013T 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen ATE445704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0043996A KR100408844B1 (ko) 2000-07-29 2000-07-29 동물세포 발현벡터
PCT/KR2001/001285 WO2002014525A2 (en) 2000-07-29 2001-07-27 Expression vector using for animal cell

Publications (1)

Publication Number Publication Date
ATE445704T1 true ATE445704T1 (de) 2009-10-15

Family

ID=19680759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957013T ATE445704T1 (de) 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen

Country Status (10)

Country Link
US (1) US7422874B2 (de)
EP (1) EP1392835B1 (de)
JP (1) JP4138479B2 (de)
KR (1) KR100408844B1 (de)
CN (1) CN1262663C (de)
AT (1) ATE445704T1 (de)
AU (1) AU2001278797A1 (de)
DE (1) DE60140218D1 (de)
ES (1) ES2333774T3 (de)
WO (1) WO2002014525A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG141239A1 (en) * 2001-01-26 2008-04-28 Selexis Sa Matrix attachment regions and methods for use thereof
NZ571508A (en) 2002-05-24 2010-05-28 Schering Corp Neutralizing human anti-IGFR antibody
WO2004027072A2 (en) * 2002-09-20 2004-04-01 Novo Nordisk A/S Method for making recombinant proteins
US6933136B2 (en) 2002-09-20 2005-08-23 Novo Nordisk A/S Method for making recombinant proteins
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화
US7135338B2 (en) * 2003-06-11 2006-11-14 Dobeel Corporation Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
KR101229989B1 (ko) 2003-10-24 2013-02-06 셀렉시스 에스. 에이. Ｍａｒ 서열의 복합 트랜스펙션 방법에 의한 포유동물 세포에서의 고효율 유전자 전달 및 발현
US7326567B2 (en) 2003-11-12 2008-02-05 Schering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
BRPI0419151A (pt) * 2004-10-28 2007-12-11 Dobeel Co Ltd método para a produção em massa de lectina ligante de manose multimérica
DE602006014942D1 (de) * 2005-03-04 2010-07-29 Celltrion Inc Expressionsvektor für tierische zelle mit wenigstens einer kopie von mar-dna-sequenzen am 3'-ende des transkriptionsterminationsbereichs eines gens sowie verfahren zur expression eines fremdgens unter verwendung des vektors
KR100779761B1 (ko) * 2005-10-28 2007-11-30 대한민국 인슐린 억제 및 사람 ｉｄｅ 유전자로 형질전환된 동물 및그 제조방법
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Ｈｂｖ 백신 및 그의 제조 방법
WO2008153366A2 (en) 2007-06-15 2008-12-18 Mogam Biotechnology Research Institute Method for manufacturing active recombinant blood coagulation factor ix
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
EP2304027A1 (de) * 2008-06-10 2011-04-06 ISIS Innovation Limited Proteinexpression
KR101054362B1 (ko) 2008-07-03 2011-08-05 재단법인 목암생명공학연구소 재조합 단백질의 푸코스 함량을 감소시키는 방법
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
EP2412810B1 (de) * 2009-03-27 2015-07-08 Hiroshima University Verfahren zur amplifikation und hochgradigen expression eines zielgens in säugerzellen und kit zur durchführung dieses verfahrens
JP2013505013A (ja) * 2009-09-18 2013-02-14 セレクシス エス．エー． 強化導入遺伝子発現およびプロセッシングの産物および方法
US20130034875A1 (en) * 2009-10-01 2013-02-07 Toto Ltd. Dna construct, and process for production of recombinant cho cell using same
MX2012003816A (es) * 2009-10-01 2012-07-04 Toto Ltd Construccion de adn y procedimiento para la generacion de celulas cho recombinantes usando la misma.
JP5888616B2 (ja) 2010-10-08 2016-03-22 カディラ・ヘルスケア・リミテッド 組換えタンパク質の高レベル発現用の発現ベクター
WO2012134215A2 (ko) * 2011-03-30 2012-10-04 (주)팬젠 동물세포 발현벡터
US10175183B2 (en) 2011-03-31 2019-01-08 Kunimine Industries Co., Ltd. Agent for searching for protein crystallization conditions and method of searching for protein crystallization conditions
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법
ES2806146T3 (es) 2011-09-22 2021-02-16 Amgen Inc Proteínas de unión al antígeno CD27L
MX355624B (es) * 2011-12-22 2018-04-25 Hoffmann La Roche Combinaciones de elementos de vector de expresion, metodos novedosos de generacion de celulas de produccion y su uso para la produccion recombinante de polipeptidos.
ES2791758T3 (es) 2011-12-22 2020-11-05 Hoffmann La Roche Organización de vectores de expresión, procedimientos de generación de células de producción novedosos y su uso para la producción recombinante de polipéptidos
AR091069A1 (es) 2012-05-18 2014-12-30 Amgen Inc Proteinas de union a antigeno dirigidas contra el receptor st2
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9580486B2 (en) 2013-03-14 2017-02-28 Amgen Inc. Interleukin-2 muteins for the expansion of T-regulatory cells
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
CN103194455B (zh) * 2013-04-08 2014-10-15 山东省农业科学院畜牧兽医研究所 高效表达的猪粒细胞巨噬细胞集落刺激因子基因及其表达蛋白的用途
CN110511279B (zh) 2013-05-30 2024-03-29 基尼克萨制药有限公司 制瘤素m受体抗原结合蛋白
JP6668241B2 (ja) 2013-09-05 2020-03-18 アムジエン・インコーポレーテツド 予測可能で、一貫性のある、且つ再現可能な糖型特性を示すＦｃ含有分子
EP3041935A1 (de) 2013-09-05 2016-07-13 Sage Therapeutics, Inc. Antisense-induzierter exon2-einschluss in saurer alpha-glucosidase
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
EA201792250A1 (ru) 2015-04-10 2018-05-31 Эмджен Инк. Мутеины интерлейкина-2 для роста регуляторных т-клеток
CA2980189A1 (en) 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
CN108138147B (zh) 2015-09-22 2022-11-01 豪夫迈·罗氏有限公司 含Fc蛋白的表达
KR20180069839A (ko) 2015-10-08 2018-06-25 자임워크스 인코포레이티드 카파 및 람다 경사슬을 포함하는 항원-결합 폴리펩티드 구조체 및 이의 용도
BR112018007356A2 (pt) 2015-11-02 2018-10-23 Genentech Inc métodos de produção de formas fucosiladas e não fucosiladas de uma proteína
WO2017184529A1 (en) 2016-04-18 2017-10-26 Sarepta Therapeutics, Inc. Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
JP7422480B2 (ja) 2016-05-04 2024-01-26 アムジエン・インコーポレーテツド 制御性ｔ細胞の増殖のためのインターロイキン－２変異タンパク質
WO2018150345A1 (en) * 2017-02-16 2018-08-23 De Vita Bio Life Sciences An expression vector
AU2018292438A1 (en) 2017-06-30 2019-12-12 Zymeworks Bc Inc. Stabilized chimeric fabs
CN110343718A (zh) * 2018-04-03 2019-10-18 新乡医学院 一种高效稳定的细胞表达载体、表达系统及其制备方法、应用
AU2020328038A1 (en) 2019-08-13 2022-03-31 Amgen Inc. Interleukin-2 muteins for the expansion of T-regulatory cells
KR20220114595A (ko) 2019-12-17 2022-08-17 암젠 인크 치료에서의 사용을 위한 이중 인터류킨-2/tnf 수용체 효현제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
CA2147006C (en) 1992-10-05 2004-11-30 William F. Thompson Method for increasing expression and reducing expression variability of foreign genes in plant cells
WO1994023041A2 (en) * 1993-04-02 1994-10-13 Ribogene, Inc. Method for selective inactivation of viral replication
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
IL127215A0 (en) 1996-06-06 1999-09-22 Novartis Ag Vectors comprising sar elements
NZ333323A (en) 1996-06-11 2000-02-28 Pioneer Hi Bred Int A synthetic plant core promoter
US6245974B1 (en) 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions
KR100313559B1 (ko) 1998-07-22 2002-03-08 허영섭 수용성 TGFβ 수용체를 발현하는 재조합 세포주 및 전기세포주를 이용한 암치료 방법
EP1117815A1 (de) * 1998-09-29 2001-07-25 Pioneer Hi-Bred International Inc. Mar/sar elemente, die ein durch rsyn7 reguliertes konstrukt flankieren
SG141239A1 (en) * 2001-01-26 2008-04-28 Selexis Sa Matrix attachment regions and methods for use thereof

Also Published As

Publication number Publication date
JP4138479B2 (ja) 2008-08-27
DE60140218D1 (de) 2009-11-26
US20040038394A1 (en) 2004-02-26
WO2002014525A2 (en) 2002-02-21
ES2333774T3 (es) 2010-03-01
KR20020010327A (ko) 2002-02-04
EP1392835A2 (de) 2004-03-03
JP2004506428A (ja) 2004-03-04
US7422874B2 (en) 2008-09-09
EP1392835A4 (de) 2006-04-19
CN1444657A (zh) 2003-09-24
AU2001278797A1 (en) 2002-02-25
CN1262663C (zh) 2006-07-05
EP1392835B1 (de) 2009-10-14
KR100408844B1 (ko) 2003-12-06
WO2002014525A3 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
DE60140218D1 (de) Expressionsvektor für tierische zellen
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
DK1137797T3 (da) Ekspressionssystem for faktor VIII
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
ATE291586T1 (de) Humanes antibiotisches protein
HUP0003116A2 (hu) Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
HUP0000280A2 (hu) Kutyaféle OB-fehérje összetételek és eljárások előállításukra
WO2001042287A3 (en) Putative human g-protein coupled receptors
MY143222A (en) Expression vector for animal cell
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
WO2003082206A3 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
DK0811068T3 (da) Humane DNase I varianter
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
NO991227L (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2001029231A3 (en) Genetic switch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties